Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
about
Antiresorptive treatment-associated ONJ.Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned.Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ).Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases.
P2860
Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bone scintigraphy predicts bis ...... stant prostate cancer (mCRPC).
@en
type
label
Bone scintigraphy predicts bis ...... stant prostate cancer (mCRPC).
@en
prefLabel
Bone scintigraphy predicts bis ...... stant prostate cancer (mCRPC).
@en
P2093
P2860
P1476
Bone scintigraphy predicts bis ...... stant prostate cancer (mCRPC).
@en
P2093
Andreas Neisius
Christian Hampel
Christian Thomas
Christian Walter
Christina Engel
Frederik C Roos
Joachim W Thüroff
Magdalena Spanidis
Matthias Miederer
Peter Rubenwolf
P2860
P304
P356
10.1007/S00784-015-1563-8
P577
2015-08-26T00:00:00Z